Oramed Pharmaceuticals Inc (ORMP)
2.22
-0.15
(-6.33%)
USD |
NASDAQ |
Apr 25, 13:19
Oramed Pharmaceuticals Shareholders Equity (Quarterly): 163.82M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 163.82M |
September 30, 2023 | 149.13M |
June 30, 2023 | 151.55M |
March 31, 2023 | 150.97M |
December 31, 2022 | 151.81M |
September 30, 2022 | 153.81M |
June 30, 2022 | 153.70M |
March 31, 2022 | 162.35M |
November 30, 2021 | 170.16M |
August 31, 2021 | 115.77M |
May 31, 2021 | 68.12M |
February 28, 2021 | 49.44M |
November 30, 2020 | 28.21M |
August 31, 2020 | 32.88M |
May 31, 2020 | 34.11M |
February 29, 2020 | 16.09M |
November 30, 2019 | 17.16M |
August 31, 2019 | 19.39M |
May 31, 2019 | 21.56M |
February 28, 2019 | 25.35M |
November 30, 2018 | 28.86M |
August 31, 2018 | 31.11M |
May 31, 2018 | 16.66M |
February 28, 2018 | 20.48M |
November 30, 2017 | 22.74M |
Date | Value |
---|---|
August 31, 2017 | 19.24M |
May 31, 2017 | 19.81M |
February 28, 2017 | 21.32M |
November 30, 2016 | 23.99M |
August 31, 2016 | 26.19M |
May 31, 2016 | 30.98M |
February 29, 2016 | 32.70M |
November 30, 2015 | 22.54M |
August 31, 2015 | 24.83M |
May 31, 2015 | 21.33M |
February 28, 2015 | 22.34M |
November 30, 2014 | 23.70M |
August 31, 2014 | 20.79M |
May 31, 2014 | 21.97M |
February 28, 2014 | 23.33M |
November 30, 2013 | 7.305M |
August 31, 2013 | 8.131M |
May 31, 2013 | 4.159M |
February 28, 2013 | 5.248M |
November 30, 2012 | 6.250M |
August 31, 2012 | 3.778M |
May 31, 2012 | 1.972M |
February 29, 2012 | 2.398M |
November 30, 2011 | 3.317M |
August 31, 2011 | 3.724M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
16.09M
Minimum
Feb 2020
170.16M
Maximum
Nov 2021
95.26M
Average
115.77M
Median
Aug 2021
Shareholders Equity (Quarterly) Benchmarks
Inogen Inc | 204.81M |
Petros Pharmaceuticals Inc | 12.48M |
DIH Holding US Inc | -- |
NovaBay Pharmaceuticals Inc | 3.314M |
Palatin Technologies Inc | -11.38M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 220.55M |
Total Liabilities (Quarterly) | 57.66M |